Tema Heart & Health ETF (NASDAQ:HRTS) Stock Price Down 0.2% – What’s Next?

Tema Heart & Health ETF (NASDAQ:HRTS) shares traded down 0.2% during trading on Monday . The company traded as low as $35.50 and last traded at $35.59. 2,551 shares changed hands during mid-day trading, a decline of 73% from the average session volume of 9,290 shares. The stock had previously closed at $35.65.

Tema Heart & Health ETF Stock Performance

The stock has a 50-day moving average of $35.58 and a two-hundred day moving average of $32.80. The company has a market cap of $56.59 million, a P/E ratio of 22.06 and a beta of 0.97.

Tema Heart & Health ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Thursday, December 11th. Stockholders of record on Wednesday, December 10th were given a $0.4729 dividend. The ex-dividend date of this dividend was Wednesday, December 10th.

Institutional Trading of Tema Heart & Health ETF

Several institutional investors have recently bought and sold shares of HRTS. JPMorgan Chase & Co. purchased a new position in Tema Heart & Health ETF in the second quarter worth about $63,000. Jane Street Group LLC increased its position in shares of Tema Heart & Health ETF by 9.4% during the second quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock valued at $1,062,000 after acquiring an additional 3,202 shares in the last quarter. Citadel Advisors LLC bought a new stake in shares of Tema Heart & Health ETF during the third quarter valued at approximately $243,000. CoreCap Advisors LLC raised its holdings in Tema Heart & Health ETF by 17.2% in the 4th quarter. CoreCap Advisors LLC now owns 60,679 shares of the company’s stock worth $2,141,000 after acquiring an additional 8,903 shares during the last quarter. Finally, Brookstone Capital Management bought a new position in Tema Heart & Health ETF in the 4th quarter valued at approximately $364,000.

Tema Heart & Health ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.